HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 106 filers reported holding HOMOLOGY MEDICINES INC in Q3 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,372 | +32.2% | 1,173 | 0.0% | 0.00% | – |
Q2 2023 | $1,038 | -99.4% | 1,173 | -97.9% | 0.00% | – |
Q1 2022 | $172,000 | -21.5% | 56,715 | -5.7% | 0.00% | – |
Q4 2021 | $219,000 | -53.6% | 60,141 | +0.2% | 0.00% | -100.0% |
Q3 2021 | $472,000 | +9.8% | 60,009 | +1.4% | 0.00% | 0.0% |
Q2 2021 | $430,000 | +22.5% | 59,167 | +58.7% | 0.00% | – |
Q1 2021 | $351,000 | -23.7% | 37,291 | -8.5% | 0.00% | -100.0% |
Q4 2020 | $460,000 | +13.3% | 40,746 | +7.5% | 0.00% | 0.0% |
Q3 2020 | $406,000 | -37.6% | 37,908 | -11.5% | 0.00% | 0.0% |
Q2 2020 | $651,000 | +44.3% | 42,854 | +47.6% | 0.00% | 0.0% |
Q1 2020 | $451,000 | -24.3% | 29,043 | +0.9% | 0.00% | 0.0% |
Q4 2019 | $596,000 | +15.5% | 28,785 | +1.0% | 0.00% | 0.0% |
Q3 2019 | $516,000 | -3.6% | 28,500 | +4.3% | 0.00% | 0.0% |
Q2 2019 | $535,000 | -7.8% | 27,322 | +30.7% | 0.00% | 0.0% |
Q1 2019 | $580,000 | +22.1% | 20,898 | -1.7% | 0.00% | 0.0% |
Q4 2018 | $475,000 | +131.7% | 21,260 | +137.1% | 0.00% | – |
Q3 2018 | $205,000 | – | 8,966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 4,535,919 | $5,307,025 | 1.53% |
Western Standard LLC | 250,060 | $292,570 | 0.26% |
OUP Management Co., LLC | 64,000 | $74,880 | 0.17% |
Vivo Capital, LLC | 370,068 | $432,980 | 0.05% |
Temasek Holdings (Private) Ltd | 5,650,996 | $6,611,665 | 0.04% |
GEORGE KAISER FAMILY FOUNDATION | 39,320 | $46,004 | 0.01% |
American Investment Services, Inc. | 36,955 | $43,238 | 0.01% |
RBF Capital, LLC | 58,700 | $68,679 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,100 | $216,567 | 0.01% |
XTX Topco Ltd | 21,188 | $24,790 | 0.00% |